Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Gazyva/Gazyvaro

PharmaCompass

01

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

02

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

03

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

04

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

05

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

06

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

Brand Name : Gazyva/Gazyvaro

arrow
IOPC
Not Confirmed

Obinutuzumab

Main Therapeutic Indication : Hematology

Currency : USD

2024 Revenue in Millions : 1,002

2023 Revenue in Millions : 941

Growth (%) : 7

blank

07

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

08

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed

09

Brand Name : Gazyva/Gazyvaro

Obinutuzumab

arrow
IOPC
Not Confirmed